ZI

Healthcare · Pharmaceuticals

Zim Laboratories Ltd (ZIMLAB)

₹147.80

Mkt cap
₹730 Cr
P/E ratio
353.00
P/B
2.71
Div yield
0.00%
ROE
1.59%
ROCE
4.76%
EPS (TTM)
₹0.42
Book value
₹55
52W range
59–160
Sector
Healthcare

Price history

Previous close

Incorporated in 1989, Zim Laboratories Ltd manufactures formulation drugs and pre formulation ingredients in India and markets and sells these within and out side India [1]

NSE ZIMLABBSE 541400
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthLow
TechnicalsBullish
52-week range
−7.52% from high
₹148
₹59+149.20% from low₹160
Current
₹147.80
Prev close
₹148.82
Day
−0.69%
Price performance
1D
−0.55%
1W
+5.05%
1M
+12.02%
3M
+22.31%
6M
+47.84%
1Y
+100.03%
YTD
+109.85%

Financials

Revenue, profit & margin
P/E ratio
353.0×
ZIMLAB is 958% above the sector median of 33.4×
ZIMLAB353.0×
Sector median33.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales85.8396.29117.8681.8292.1496.33108.7371.7688.71108.66105.2794.18105.45
YoY Sales growth-13.65%-4.64%+11.81%+21.32%+7.35%+0.04%-7.75%-12.30%-3.72%+12.80%-3.18%+31.24%+18.87%
Expenses76.5084.75102.2173.7882.6184.7794.1367.5182.9595.8598.0891.73100.02
Operating Profit9.3311.5415.658.049.5311.5614.604.255.7612.817.192.455.43
OPM %10.87%11.98%13.28%9.83%10.34%12.00%13.43%5.92%6.49%11.79%6.83%2.60%5.15%
Other Income1.421.111.531.001.321.751.711.482.041.706.160.992.30
Interest1.221.702.282.862.892.732.913.303.163.433.313.643.94
Depreciation4.093.943.914.945.004.885.294.864.985.035.105.376.53
Profit before tax5.447.0110.991.242.965.708.11-2.43-0.346.054.94-5.57-2.74
Tax %23.71%31.81%26.48%27.42%19.59%30.00%39.70%-22.63%23.53%27.27%24.29%-28.01%-25.18%
Net Profit4.154.788.090.902.384.004.88-1.87-0.424.403.74-4.02-2.05
EPS in Rs0.850.981.660.180.490.821.00-0.38-0.090.900.70-0.75-0.38
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −4.17% · closed higher next day 0 of last 2
 Q1FY27Q2FY27
Broadcast6 Aug '264 Nov '26
Earnings day−2.75%−5.59%
+1 day−3.46%−3.83%
+5 days−6.60%−0.96%
+15 days+8.95%—
+30 days+16.07%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
30.30%Promoter
Promoters30.30%0.06
FIIs0.17%0.14
DIIs1.19%0.15
Public68.35%0.07
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,870.0036.464,48,6760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,150.0086.622,95,9970.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,668.8081.801,77,5860.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,338.0094.281,26,3250.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,204.2026.511,20,1190.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,388.0041.411,15,9360.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,388.0036.111,12,1350.94%852−35.05%7,404−2.44%15.49%
Zim Laboratories₹135.99352.517300.00%−2−388.10%105+18.87%4.76%
Median: 160 Co.₹445.7333.352,0160.08%13+33.73%179+21.23%14.94%

Filings